New study aims to get seniors off risky diabetes drugs

NCT ID NCT05933174

Recruiting now Disease control Sponsor: Ian J. Neeland, MD Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study helps older adults with type 2 diabetes talk to their doctors about switching from sulfonylurea drugs, which can cause dangerous low blood sugar and heart problems, to newer, safer options. About 220 participants will get either a simple question sheet to guide their next doctor visit or a general brochure. The goal is to see if this approach leads to more conversations and safer medication use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: question prompt sheet
What this could lead to: If this works, it could help older adults with type 2 diabetes switch from risky sulfonylurea drugs to safer, more effective medications, reducing harm.
What could go wrong: This is a small, early-stage trial focused on conversations, not a direct test of a new drug. The intervention may not lead to actual medication changes or improved health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE2DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE2DIABETES

Contacts and locations

Locations

University Hospitals Cleveland Medical Center
RECRUITING

Cleveland, Ohio, 44106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.